Ensign Peak Advisors, Inc Natera, Inc. Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q1 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 273,425 shares of NTRA stock, worth $29.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

273,425

Previous 36,900 640.99%

Holding current value

$29.1 Million

Previous $2.31 Million 982.09%

% of portfolio

0.05%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$59.21 - $92.9 $14 Million - $22 Million	236,525 Added 640.99%	273,425 $25 Million
Q4 2022 Feb 13, 2023	SELL	$34.17 - $47.91 $3.51 Million - $4.93 Million	-102,832 Reduced 73.59%	36,900 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $2.1 Million - $3.22 Million	56,814 Added 68.52%	139,732 $6.12 Million
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $533,541 - $844,790	-18,967 Reduced 18.62%	82,918 $2.94 Million
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $3.73 Million - $5.15 Million	43,256 Added 73.78%	101,885 $9.52 Million

Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $3.23 Million - $4.07 Million	32,196 Added 121.8%	58,629 $6.53 Million
Q1 2021 May 12, 2021	SELL	$91.47 - $124.36 $777,312 - $1.06 Million	-8,498 Reduced 24.33%	26,433 $2.68 Million
Q4 2020 Feb 12, 2021	SELL	$66.66 - $111.74 $384,428 - $644,404	-5,767 Reduced 14.17%	34,931 $3.48 Million
Q3 2020 Nov 12, 2020	BUY	$45.89 - $72.67 $1.76 Million - $2.79 Million	38,380 Added 1655.74%	40,698 $2.94 Million
Q1 2020 May 11, 2020	SELL	$17.27 - $40.17 $40,049 - $93,154	-2,319 Reduced 50.01%	2,318 $69,000
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $148,847 - $187,334	4,637 New	4,637 $156,000

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Natera, Inc. Transaction History